Q2 2015 Holdings
Filed 2015-08-14 | 97 holdings | $116.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Angiodynamics Inc(ANGO) | COM | 03475V101 | $39.3M | 2,398,527 | 33.9% |
| Amphastar Pharmaceuticals in(AMPH) | COM | 03209R103 | $24.9M | 1,417,956 | 21.5% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $17.3M | 4,183,177 | 14.9% |
| Atricure Inc(ATRC) | COM | 04963C209 | $11.9M | 483,354 | 10.3% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $8.9M | 964,193 | 7.7% |
| Accuray Inc(ARAY) | COM | 004397105 | $6.7M | 1,000,000 | 5.8% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $5.3M | 297,200 | 4.6% |
| Ishares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $218.5K | 1,750,000 | 0.2% |
| Horizon Pharma PLC | SHS | G4617B105 | $167.3K | 4,815,807 | 0.1% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $105.4K | 4,975,184 | 0.1% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $74.7K | 2,396,681 | 0.1% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $71.9K | 285,000 | 0.1% |
| Retrophin Inc | COM | 761299106 | $71.7K | 2,162,928 | 0.1% |
| Progenics Pharmaceuticals in | COM | 743187106 | $66.8K | 8,951,169 | 0.1% |
| Emergent Biosolutions Inc(EBS) | COM | 29089Q105 | $58.0K | 1,760,519 | 0.0% |
| Aegerion Pharmaceuticals Inc | COM | 00767E102 | $54.1K | 2,852,578 | 0.0% |
| Horizon Pharma PLCCall | SHS | G4617B105 | $38.2K | 1,100,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $34.1K | 2,256,546 | 0.0% |
| Pernix Therapeutics Hldgs in | COM | 71426V108 | $30.0K | 5,075,929 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $29.5K | 1,450,094 | 0.0% |
| Biodelivery Sciences Intl in(BDSIUSD) | COM | 09060J106 | $28.2K | 3,544,060 | 0.0% |
| Depomed Inc | COM | 249908104 | $25.1K | 1,167,442 | 0.0% |
| Alere Inc | COM | 01449J105 | $23.9K | 452,423 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $22.6K | 419,559 | 0.0% |
| Idera Pharmaceuticals Inc | COM NEW | 45168K306 | $21.0K | 5,663,845 | 0.0% |
| Raptor Pharmaceutical Corp | COM | 75382F106 | $20.8K | 1,319,883 | 0.0% |
| Corium Intl Inc | COM | 21887L107 | $20.6K | 1,504,762 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $18.9K | 5,876,752 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $18.6K | 759,470 | 0.0% |
| QLT Inc | COM | 746927102 | $18.4K | 4,445,527 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $18.3K | 1,413,533 | 0.0% |
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | $18.1K | 2,650,000 | 0.0% |
| Zogenix Inc | COM | 98978L105 | $18.0K | 10,737,645 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $17.9K | 766,010 | 0.0% |
| Aratana Therapeutics Inc(PETXEUR) | COM | 03874P101 | $17.1K | 1,131,865 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $16.6K | 1,812,419 | 0.0% |
| Derma Sciences Inc | COM PAR $.01 | 249827502 | $16.6K | 2,317,489 | 0.0% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $15.8K | 7,575,000 | 0.0% |
| Kempharm Inc | COM | 488445107 | $15.2K | 827,810 | 0.0% |
| IGI Labs Inc | COM | 449575109 | $14.4K | 2,287,728 | 0.0% |
| Cynapsus Therapeutics Inc | COM PAR NO PAR | 23257Y859 | $13.9K | 878,117 | 0.0% |
| Pernix Therapeutics Hldgs in | DEBT 4.250% 4/0 | 71426VAJ7 | $13.8K | 15,500,000 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $13.7K | 996,760 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $13.7K | 530,283 | 0.0% |
| Anthera Pharmaceuticals Inc | COM NEW | 03674U201 | $11.8K | 1,370,457 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $11.3K | 359,661 | 0.0% |
| Syneron Medical LTD | ORD SHS | M87245102 | $10.7K | 1,005,221 | 0.0% |
| Alcobra LTD | SHS | M2239P109 | $10.3K | 1,579,806 | 0.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $8.9K | 649,290 | 0.0% |
| Trevena Inc | COM | 89532E109 | $8.8K | 1,409,153 | 0.0% |